Increasing the Infliximab Dose Is Beneficial in Crohn’s Disease Patients Who Responded to a Lower Dose and Relapsed

Publisher: Karger

E-ISSN: 1421-9867|72|2-3|124-128

ISSN: 0012-2823

Source: Digestion, Vol.72, Iss.2-3, 2005-10, pp. : 124-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content